Predicting the Likelihood of Additional Nodal Metastases in Breast Carcinoma Patients With Positive Sentinel Node Biopsy

Abstract

Axillary lymph node dissection (ALND) is an important procedure in the staging of breast cancer patients. However, it is associated with a significant morbidity rate. In addition, using early diagnosis a high number of cases with negative lymph nodes can be identified. A lymph node defined as sentinel lymph node (SLN) would be the first to receive tumoral drainage. A less morbid but accurate staining procedure using mapping and SLN biopsy has been introduced. The aim of this study was to estimate the likelihood of additional disease in the axilla after SLN analysis. A total of 259 breast carcinomas and SLN biopsies followed by ALND were examined. The patient median age was 59 years, approximately 75% of them postmenopausal. Tumor size was 1.4 ± 0.8 cm (almost 80% in pT1). SLNs were positive in 59 of 259 (22.8%) carcinomas, 30 (11.6%) with micrometastases (<2.0 mm) and 29 (11.2%) with metastases. Tumor size ( P = .004) and presence of lymphovascular invasion (LVI; P = .034) were found to be significant predictors of pathologically positive SLN. Following ALND, positive non-SLNs were present mostly in patients with metastasis >2 mm in SLN (P = .003), in carcinoma with higher nuclear grade ( P = .044), decreased estrogen receptor (ER; P = .042), and progesterone receptor (PR; P = .042). Finally, lymph node status (pN) following SLN and ALND was found to be significantly associated with tumor size ( P = .006), LVI (P = .037), PR (P = .023), and Her-2 status (P < .001). These results point to detailed analysis of primary tumor and SLN that may increase the precision of patient selection for further axillary surgery or radiotherapy.

Keywords

breast neoplasm metastasis sentinel lymph node axillary lymph node dissection

References

Dees EC , Shulman LN , Souba WW , Smith BL Does information from axillary dissection change treatment in clinically non-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection. Ann Surg. 1997;226:279-286.

Veronesi U. , Paganelli G. , Galimberti V. , et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet. 1997;349: 1864-1867.

Krag D. , Weaver D. , Ashikaga T. , et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med. 1998;339:941-946.

Miltenberg DM , Miller C. , Karamlou TB , Brunicardi C. Meta-analysis of sentinel lymph node biopsy . J Surg Res. 1999;84:138-142.

Veronesi U. , Paganelli G. , Viale G. , et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999;91:368-373.

Giuliano AE , Haigh PI , Brennan MB , et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 2000;18: 2553-2559.

Lyman GH , Giuliano AE , Somerfield MR , et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703-7720.

Chu KU , Turner RR , Hansen NM , Brennan MB , Bilchik A. , Giuliano AE Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg. 1999;229:536-541.

Reynolds C. , Mick R. , Donohue JH , et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol . 1999;17:1720-1726.

10.

Turner RR , Ollila DW , Krasne DL , Giuliano AE Histologic validation of the sentinel lymph node hypothesis for breast carcinoma . Ann Surg. 1997;226:271-278.

11.

Rahusen FD , Torrenga H. , van Diest PJ , et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg. 2001;182:316-320.

12.

Weiser MR , Montgomery LL , Tan LK , et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol. 2001;8:145-149.

13.

Abdessalam SF , Zevos EE , Prasad M. , et al. Predictors of positive axillary lymph nodes after sentinel lymph biopsy in breast cancer . Am J Surg . 2001;182:316-320.

14.

Sachdev U. , Murphy K. , Derzie A. , Jaffer S. , Bleiweiss IJ , Brower S. Predictors of nonsentinel lymph node metastasis in breast cancer patients . Am J Surg. 2002;183: 213-217.

15.

Hunt JL , Baloch ZW , LiVolsi VA Sentinel lymph node evaluation for tumor metastasis. Semin Diagn Pathol. 2002;19:263-277.

16.

Schwartz GF , Giuliano AE , Veronesi U. ; Consensus Conference Committee. Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast. April 19-22, 2001; Philadelphia, PA. Hum Pathol . 2002;33:579-589.

17.

Jonjić N. , Mustać E. , Dekanić A. , et al. Predicting sentinel lymph node metastases in infiltrating breast carcinoma with vascular invasion . Int J Surg Pathol. 2006;14:306-311.

18.

Turner RR , Chu KU , Qi K. , et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in sentinel lymph node. Cancer. 2000;89:574-581.

19.

Samailova E. , Davis JT , Hinson J. , et al. Size of sentinel node tumor deposits and extent of axillary lymph node involvement: which breast cancer patients may benefit from less aggressive axillary dissections? Ann Surg Oncol. 2007;14:3040-3042.

20.

Cserni G. , Bianchi S. , Vezzosi V. , et al. Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European Multi-Institutional Study. Pathol Oncol Res. 2007;13:5-14.

21.

Viale G. , Maiorano E. , Mazzzarol G. , et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer. 2001;15:1378-1384.

22.

Herbert GS , Sohn VY , Brown TA The impact of nodal isolated cells on survival of breast cancer patients . Am J Surg. 2007;193:571-573.

23.

Cserni G. Axillary sentinel lymph node micrometastases with extracapsular extension: a distinct pattern of breast cancer metastasis? J Clin Pathol . 2008;61:115-118.

24.

Bader AA , Tio J. , Petru E. , et al. T1 breast cancer: identification of patients at low risk of axillary lymph node metastases. Breast Cancer Res Treat. 2002;76:11-17.

25.

Van Zee KJ , Manasseh DME , Bevilacqua JLB , et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10:1140-1151.

26.

Ponzone R. , Maggiorotto F. , Mariani L. , et al. Comparison of two models for the prediction of nonsentinel node metastases in breast cancer. Am J Surg. 2007 ;193:686-692.